{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:34:02Z","timestamp":1782484442350,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003141","name":"consejo nacional de ciencia y tecnolog\u00eda","doi-asserted-by":"publisher","award":["FOSISS-273213"],"award-info":[{"award-number":["FOSISS-273213"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12035-021-02536-1","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T20:59:34Z","timestamp":1630702774000},"page":"6222-6231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["circRNA Regulates Dopaminergic Synapse, MAPK, and Long-term Depression Pathways in Huntington Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Ernesto","family":"Marfil-Marin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Santamar\u00eda-Olmedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"PerezGrovas-Saltijeral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Valdes-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ochoa-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Jara-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Sevilla-Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Camacho-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-8784","authenticated-orcid":false,"given":"Alberto","family":"Hidalgo-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"2536_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L (2016) The prevalence of Huntington\u2019s disease. Neuroepidemiology. 46:144\u2013153","journal-title":"Neuroepidemiology."},{"key":"2536_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E et al (2019) Targeting Huntingtin expression in patients with Huntington\u2019s disease. N Engl J Med 380:2307\u20132316","journal-title":"N Engl J Med"},{"key":"2536_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"2536_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of huntingtin. Neuron. 89:910\u2013926","journal-title":"Neuron."},{"key":"2536_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR, International Huntington\u2019s Disease Collaborative Group (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65:267\u2013277","journal-title":"Clin Genet"},{"key":"2536_CR6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/iub.111","volume":"60","author":"DM Hatters","year":"2008","unstructured":"Hatters DM (2008) Protein misfolding inside cells: the case of huntingtin and Huntington\u2019s disease. IUBMB Life 60:724\u2013728","journal-title":"IUBMB Life"},{"key":"2536_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/gm80","volume":"1","author":"JF Gusella","year":"2009","unstructured":"Gusella JF, MacDonald ME (2009) Huntington\u2019s disease: the case for genetic modifiers. Genome Med 1:80","journal-title":"Genome Med"},{"key":"2536_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2009.02.007","volume":"136","author":"PA Sharp","year":"2009","unstructured":"Sharp PA (2009) The centrality of RNA. Cell. 136:577\u2013580","journal-title":"Cell."},{"key":"2536_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/1535370217708978","volume":"242","author":"KY Hsiao","year":"2017","unstructured":"Hsiao KY, Sun HS, Tsai SJ (2017) Circular RNA - new member of noncoding RNA with novel functions. Exp Biol Med (Maywood) 242:1136\u20131141","journal-title":"Exp Biol Med (Maywood)"},{"key":"2536_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","volume":"159","author":"XO Zhang","year":"2014","unstructured":"Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L (2014) Complementary sequence-mediated exon circularization. Cell. 159:134\u2013147","journal-title":"Cell."},{"key":"2536_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25:981\u2013984","journal-title":"Cell Res"},{"key":"2536_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00109-017-1582-9","volume":"95","author":"PG Maass","year":"2017","unstructured":"Maass PG, Gla\u017ear P, Memczak S, Dittmar G, Hollfinger I, Schreyer L, Sauer AV, Toka O, Aiuti A, Luft FC, Rajewsky N (2017) A map of human circular RNAs in clinically relevant tissues. J Mol Med (Berl) 95:1179\u20131189","journal-title":"J Mol Med (Berl)"},{"key":"2536_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Gla\u017ear P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, Herzog M, Schreyer L, Papavasileiou P, Ivanov A, \u00d6hman M, Refojo D, Kadener S, Rajewsky N (2015) Circular RNAs in the Mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 58:870\u2013885","journal-title":"Mol Cell"},{"key":"2536_CR14","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.3390\/ijms20215477","volume":"20","author":"E D'Ambra","year":"2019","unstructured":"D'Ambra E, Capauto D, Morlando M (2019) Exploring the regulatory role of circular RNAs in neurodegenerative disorders. Int J Mol Sci 20:5477. https:\/\/doi.org\/10.3390\/ijms20215477","journal-title":"Int J Mol Sci"},{"key":"2536_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fphys.2018.01262","volume":"9","author":"LM Holdt","year":"2018","unstructured":"Holdt LM, Kohlmaier A, Teupser D (2018) Circular RNAs as therapeutic agents and targets. Front Physiol 9:1262","journal-title":"Front Physiol"},{"key":"2536_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1517\/17530059.2012.701205","volume":"6","author":"RI Scahill","year":"2012","unstructured":"Scahill RI, Wild EJ, Tabrizi SJ (2012) Biomarkers for Huntington\u2019s disease: an update. Expert Opin Med Diagn 6:371\u2013375","journal-title":"Expert Opin Med Diagn"},{"key":"2536_CR17","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","volume":"10","author":"A Wyttenbach","year":"2001","unstructured":"Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC (2001) Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease. Hum Mol Genet 10:1829\u20131845","journal-title":"Hum Mol Genet"},{"key":"2536_CR18","doi-asserted-by":"publisher","first-page":"W741","DOI":"10.1093\/nar\/gki475","volume":"33","author":"B Zhang","year":"2005","unstructured":"Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741\u2013W748","journal-title":"Nucleic Acids Res"},{"key":"2536_CR19","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"2536_CR20","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/hmg\/9.9.1433","volume":"9","author":"H Yanagisawa","year":"2000","unstructured":"Yanagisawa H, Bundo M, Miyashita T, Okamura-Oho Y, Tadokoro K, Tokunaga K, Yamada M (2000) Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine. Hum Mol Genet 9:1433\u20131442","journal-title":"Hum Mol Genet"},{"key":"2536_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1242\/dev.00908","volume":"131","author":"JS Zoltewicz","year":"2004","unstructured":"Zoltewicz JS, Stewart NJ, Leung R, Peterson AS (2004) Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis. Development. 131:3\u201314","journal-title":"Development."},{"key":"2536_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ajhg.2016.03.002","volume":"98","author":"B Fregeau","year":"2016","unstructured":"Fregeau B, Kim BJ, Hern\u00e1ndez-Garc\u00eda A, Jordan VK, Cho MT, Schnur RE, Monaghan KG, Juusola J, Rosenfeld JA, Bhoj E, Zackai EH, Sacharow S, Bara\u00f1ano K, Bosch DGM, de Vries BBA, Lindstrom K, Schroeder A, James P, Kulch P et al (2016) De novo mutations of RERE Cause a genetic syndrome with features that overlap those associated with proximal 1p36 deletions. Am J Hum Genet 98:963\u2013970","journal-title":"Am J Hum Genet"},{"key":"2536_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ng0194-14","volume":"6","author":"S Nagafuchi","year":"1994","unstructured":"Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 6:14\u201318","journal-title":"Nat Genet"},{"key":"2536_CR24","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch ET, Raymond LA (2019) Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J Neurosci Res 97:1636\u20131654","journal-title":"J Neurosci Res"},{"key":"2536_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.clineuro.2010.07.014","volume":"112","author":"J Gamez","year":"2010","unstructured":"Gamez J, Lorenzo-Bosquet C, Cuberas-Borr\u00f3s G, Carmona F, Hern\u00e1ndez-Vara J, Castill\u00f3 J, Castell-Conesa J (2010) Does reduced [(123)I]-FP-CIT binding in Huntington\u2019s disease suggest pre-synaptic dopaminergic involvement? Clin Neurol Neurosurg 112:870\u2013875","journal-title":"Clin Neurol Neurosurg"},{"key":"2536_CR26","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","volume":"28","author":"P Paoletti","year":"2008","unstructured":"Paoletti P, Vila I, Rif\u00e9 M, Lizcano JM, Alberch J, Gin\u00e9s S (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5. J Neurosci 28:10090\u201310101","journal-title":"J Neurosci"},{"key":"2536_CR27","doi-asserted-by":"publisher","first-page":"6-016-0053-5","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"SS S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen SS, Nygaard AB, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia - an exploratory study. Transl Neurodegener 5:6-016-0053-5 eCollection 2016","journal-title":"Transl Neurodegener"},{"key":"2536_CR28","first-page":"8814862","volume":"2021","author":"J Zhu","year":"2021","unstructured":"Zhu J, Xu X, Liang Y, Zhu R (2021) Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3\u03b2\/\u03b2-catenin signaling pathway inhibits cell apoptosis in Parkinson\u2019s disease. Biomed Res Int 2021:8814862","journal-title":"Biomed Res Int"},{"key":"2536_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","volume":"661","author":"Y Keshet","year":"2010","unstructured":"Keshet Y, Seger R (2010) The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 661:3\u201338","journal-title":"Methods Mol Biol"},{"key":"2536_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbamcr.2018.09.002","volume":"1866","author":"OM Seternes","year":"2019","unstructured":"Seternes OM, Kidger AM, Keyse SM (2019) Dual-specificity MAP kinase phosphatases in health and disease. Biochim Biophys Acta, Mol Cell Res 1866:124\u2013143","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"key":"2536_CR31","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","volume":"33","author":"DM Taylor","year":"2013","unstructured":"Taylor DM, Moser R, R\u00e9gulier E, Breuillaud L, Dixon M, Beesen AA, Elliston L, Silva Santos Mde F, Kim J, Jones L, Goldstein DR, Ferrante RJ, Luthi-Carter R (2013) MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington\u2019s disease via additive effects of JNK and p38 inhibition. J Neurosci 33:2313\u20132325","journal-title":"J Neurosci"},{"key":"2536_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/hmg\/ddi443","volume":"15","author":"BL Apostol","year":"2006","unstructured":"Apostol BL, Illes K, Pallos J, Bodai L, Wu J, Strand A, Schweitzer ES, Olson JM, Kazantsev A, Marsh JL, Thompson LM (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity. Hum Mol Genet 15:273\u2013285","journal-title":"Hum Mol Genet"},{"key":"2536_CR33","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.3390\/ijms20246157","volume":"20","author":"J Ha","year":"2019","unstructured":"Ha J, Kang E, Seo J, Cho S (2019) Phosphorylation dynamics of JNK Signaling: effects of dual-specificity phosphatases (DUSPs) on the JNK pathway. Int J Mol Sci 20:6157. https:\/\/doi.org\/10.3390\/ijms20246157","journal-title":"Int J Mol Sci"},{"key":"2536_CR34","doi-asserted-by":"publisher","first-page":"105090","DOI":"10.1016\/j.phrs.2020.105090","volume":"160","author":"T Ahmed","year":"2020","unstructured":"Ahmed T, Zulfiqar A, Arguelles S, Rasekhian M, Nabavi SF, Silva AS, Nabavi SM (2020) Map kinase signaling as therapeutic target for neurodegeneration. Pharmacol Res 160:105090","journal-title":"Pharmacol Res"},{"key":"2536_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.05.043","volume":"251","author":"J Nithianantharajah","year":"2013","unstructured":"Nithianantharajah J, Hannan AJ (2013) Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington\u2019s disease. Neuroscience. 251:66\u201374","journal-title":"Neuroscience."},{"key":"2536_CR36","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","volume":"11","author":"RJ Ferrante","year":"1991","unstructured":"Ferrante RJ, Kowall NW, Richardson EP Jr (1991) Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 11:3877\u20133887","journal-title":"J Neurosci"},{"key":"2536_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andr\u00e9 VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS (2011) Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 198:252\u2013273","journal-title":"Neuroscience."}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02536-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:49:36Z","timestamp":1699433376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02536-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02536-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"30 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article employed a modified cell line derived from the organism <i>Rattus norvegicus<\/i> obtained from the University of Cambridge. No human material was used in this study. This work does not qualify for ethics approval according to the Institutional Ethics Committees from the participant institutions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A cell line derived from the organism <i>Rattus norvegicus<\/i> (RRID:CVCL_0481) was obtained from David Rubinsztein from the Cambridge Institute of Medical Research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cell lines"}}]}}